We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




DHEA Receptor Identified in Vascular Endothelial Cells

By Biotechdaily staff writers
Posted on 25 Jun 2002
A receptor for the adrenal hormone dehydroepiandrosterone (DHEA) has been located in the cells that make up the inner lining of blood vessels. More...
DHEA and the closely related DHEAS are made mainly in the adrenal gland and circulate in the bloodstream in higher concentrations than any other steroid hormone, including estrogen or testosterone. DHEA production declines after the age of puberty, dropping to around 20% of peak levels by age 75.

A report appearing in the June 14, 2002, issue of the Journal of Biological Chemistry describes how investigators from the University of Iowa (Iowa City, USA; www.uiowa.edu) chose a novel approach to find the elusive DHEA receptor. Rather than working with immune or liver cells, as is most often done, they searched for the receptor in the cells comprising the vascular endothelium. Moreover, the receptor was found localized on the exterior surface of the cells rather than the interior surface, where hormone receptors are usually found.

"The significance of our study is that it provides a scientific basis for further study of the DHEA action in humans,” said the study's lead investigator Dr. Joseph Dillon. "Our findings show that there is a receptor for DHEA on the inner lining cells of blood vessels. The receptor responds to levels of DHEA that circulate normally within the bloodstream and links DHEA to the production of nitric oxide. Unlike research with all the other major hormones and steroids, no one had previously been able to identify a receptor for DHEA in cells.”

The next step will be to completely isolate the receptor. This will allow testing of DHEA analogues in order to eventually develop medications that could have beneficial effects in a wide range of diseases, including cancer, heart disease, obesity and diabetes.



Related Links:
University of Iowa

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Thyroid Test
Anti-Thyroid EIA Test
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.